Autoantibodies in prostate cancer [1]

New England Journal of Medicine

Volumn 353, Issue 26, 2005, Pages 2815-

  Tan, E M ^a   Koziol, James A ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR ANTIGEN; AUTOANTIBODY; PEPTIDE; PEPTIDE LIBRARY; TUMOR MARKER;

AUTOIMMUNE DISEASE; CANCER CLASSIFICATION; CANCER SCREENING; DATA ANALYSIS; EVALUATION; GENE SEQUENCE; GENETIC CODE; HUMAN; LETTER; PRIORITY JOURNAL; PROSTATE CARCINOMA; BLOOD; DECISION TREE; IMMUNOLOGY; MALE; NOTE; PROSTATE TUMOR; PROTEIN MICROARRAY; SENSITIVITY AND SPECIFICITY;

AUTOANTIBODIES; DECISION TREES; HUMANS; MALE; PEPTIDE LIBRARY; PEPTIDES; PROSTATIC NEOPLASMS; PROTEIN ARRAY ANALYSIS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 29544439973     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc055428     Document Type: Letter

References (4)

1. Wang X, Yu J, Sreekumar A, et al. Autoantibody signatures in prostate cancer. N Engl J Med 2005;353:1224-35.
2. Koziol JA, Zhang JY, Casiano CA, et al. Recursive partitioning as an approach to selection of immune markers for tumor diagnosis. Clin Cancer Res 2003;9:5120-6.
3. Suzuki H, Graziano DF, McKolanis J, Finn OJ. T cell-dependent antibody responses against aberrantly expressed cyclin B1 protein in patients with cancer and premalignant disease. Clin Cancer Res 2005;11:1521-6.
4. Fagan TJ. Nomogram for Bayes's theorem. N Engl J Med 1975;293:257.